A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

✍ Scribed by Molina, Ana M.; Hutson, Thomas E.; Larkin, James; Gold, Anne M.; Wood, Karen; Carter, Dave; Motzer, Robert; Michaelson, M. Dror

• Book ID: 121582945
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 395 KB
• Volume: 73
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-013-2339-y